Research ArticleConference Proceedings
Proceedings of the 2023 Viral Clearance Symposium, Session 4: Continuous Processing
John Fisher and Scott Lute
PDA Journal of Pharmaceutical Science and Technology March 2024, 78 (2) 169-175; DOI: https://doi.org/10.5731/pdajpst.2024.002244
John Fisher
1Process Virology, Purification Development, Genentech, a Member of the Roche Group, 1 DNA Way, South San Francisco, CA 94080; and
Scott Lute
2Center for Drug Evaluation and Research, Office of Product Quality Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993

References
- 1.↵
- Johnson S. A.,
- Roush D.
- 2.↵
- Lute S.,
- Specht R.
- 3.↵
- Hong M. S.,
- Lu A. E.,
- Ou R. W.,
- Wolfrum J. M.,
- Springs S. L.,
- Sinskey A. J.,
- Braatz R. D.
- 4.↵
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 2
March/April 2024
Proceedings of the 2023 Viral Clearance Symposium, Session 4: Continuous Processing
John Fisher, Scott Lute
PDA Journal of Pharmaceutical Science and Technology Mar 2024, 78 (2) 169-175; DOI: 10.5731/pdajpst.2024.002244
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.